Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ribozyme Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Ribozyme Pharmaceuticals

Ribozyme Pharmaceuticals

Acquired

Ribozyme Pharmaceuticals, a subsidiary of Alnylam Pharmaceuticals, develops RNAi-based therapeutics for various diseases.

HQ
Boulder, CO, US
Founded
1992
Overview
Compare
Fundraising
Employees

Ribozyme Pharmaceuticals, based in Boulder, Colorado, is a biotechnology company focused on developing RNA interference (RNAi) therapeutics. It offers research, preclinical, and clinical development services with product candidates targeting age-related macular degeneration (AMD), chronic hepatitis, dermatology, asthma, Huntington’s disease, oncology, and diabetes. Notable products include Sirna-027 for AMD, which has completed phase I clinical trials.

As a subsidiary of Alnylam Pharmaceuticals, Ribozyme Pharmaceuticals has made significant strides in RNAi technology. Its innovative approach has positioned it as a key player in the biotechnology sector, contributing to advancements in treating complex diseases. The company's work in RNAi therapeutics has the potential to transform disease management and improve patient outcomes globally.

Ribozyme Pharmaceuticals - Similar Companies

Alnylam Pharmaceuticals aln logo

Alnylam Pharmaceuticals aln

alnylam.com

Sirnaomics logo

Sirnaomics

sirnaomics.com

Quark Pharmaceuticals logo

Quark Pharmaceuticals

Ribonova logo

Ribonova

ribonova.com

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Ribometrix logo

Ribometrix

ribometrix.com

Ribon Therapeutics logo

Ribon Therapeutics

ribontx.com

Nucleonics logo

Nucleonics

Rjs Biologics logo

Rjs Biologics

Silence Therapeutics logo

Silence Therapeutics

Aldena Therapeutics logo

Aldena Therapeutics

Sirius Therapeutics logo

Sirius Therapeutics

siriusrna.com

Rnaderm Therapeutics logo

Rnaderm Therapeutics

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Rbio logo

Rbio

rbio.online

Ribozyme Pharmaceuticals - Quick Facts

Who are Ribozyme Pharmaceuticals' competitors?

Companies similar to Ribozyme Pharmaceuticals include Alnylam Pharmaceuticals aln, Sirnaomics, Quark Pharmaceuticals and Ribonova.

When was Ribozyme Pharmaceuticals founded?

Ribozyme Pharmaceuticals was founded in 1992.

Where is Ribozyme Pharmaceuticals' headquarters located?

Ribozyme Pharmaceuticals' headquarters is located in Boulder, CO, US.

When was Ribozyme Pharmaceuticals' last funding round?

Ribozyme Pharmaceuticals' most recent funding round was for $12M (USD) in July 1999.

How much has Ribozyme Pharmaceuticals raised to-date?

As of Jul 13, 1999, Ribozyme Pharmaceuticals has raised a total of $12M (USD).

Ribozyme Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified